...at the School of Medicine
Look up other people in the University Directory.
Pamela B. Davis received her B.S. in chemistry, summa cum laude, from Smith College in 1968, receiving her Ph.D. in physiology and pharmacology in 1973 and M.D. in 1974, both from Duke University. In 1981, she moved to Case Western Reserve University, where she directed the Willard A. Bernbaum Cystic Fibrosis Research Center, and pursued her research interests, specifically how the cystic fibrosis lung disease arises and strategies for gene therapy of the disease. She has brought both novel anti-inflammatory therapies and gene therapy strategies into clinical testing for cystic fibrosis.
Dr. Davis held the position of Chief of the Pediatric Pulmonary Division at Rainbow Babies and Children’s Hospital from 1985-2007. She holds the Arline H. and Curtis F. Garvin, M.D., Research Professor chair at the School of Medicine and also is a Professor of Pediatrics, Physiology & Biophysics, and Molecular Biology & Microbiology. She was named Dean of the School of Medicine at Case Western Reserve University in September 2007 after serving as the Interim Dean since September 2006.
Dr. Davis has published more than 130 original articles, mostly in the area of cystic fibrosis research. She has edited one book, contributed numerous book chapters, and served as associate editor for several journals. She holds seven U.S. patents and is a founding scientist of Copernicus Therapeutics Inc., to which some of her patents are licensed. Davis also directed the State of Ohio Biomedical Research and Technology Transfer Center on Targeted Nanoparticles for Imaging and Therapeutics, which spans not only the School of Medicine, but also the Departments of Biomedical Engineering and Chemistry. She has been continuously funded by the National Institutes of Health for 28 years, most recently as the principal investigator of the Clinical and Translational Science Award to Case Western Reserve University. She has served on the Advisory Council to NIDDK, on the Board of Scientific Counselors for the National Heart, Lung and Blood Institute (NHLBI), and on advisory boards for the Burroughs Wellcome Fund and several academic cystic fibrosis centers. In addition, the National Institutes of Health recently appointed Dr. Davis to the Working Group for Human Embryonic Stem Cell Eligibility Review.
Dr. Davis has been a recipient of the Paul Di Sant’Agnese Award from the Cystic Fibrosis Foundation, the Rosenthal Prize for academic pediatrics, the Smith College Medal, and has regularly been named in "Best Doctors in America" and "Top Doctors." She also has been inducted into the Cleveland Medical Hall of Fame and the Ohio Women’s Hall of Fame.